Introduction and Statement of Policy Clause Samples

The 'Introduction and Statement of Policy' clause serves to outline the overall purpose and guiding principles of the agreement. It typically sets the context for the contract, clarifying the intentions of the parties and the general objectives they aim to achieve. For example, it may specify the scope of the relationship, the values or standards to be upheld, or the overarching goals of the arrangement. This clause ensures that all parties have a shared understanding of the contract’s foundation, helping to prevent misunderstandings and providing a reference point for interpreting the rest of the agreement.
Introduction and Statement of Policy. The National Institutes of Health (NIH) has established NIH-designated data repositories (e.g., database of Genotypes and Phenotypes (dbGaP), Sequence Read Archive (SRA), NIH Established Trusted Partnerships) for securely storing and sharing controlled-access human data submitted to NIH under the NIH Genomic Data Sharing (GDS)
View SourceView Similar (305)
Introduction and Statement of Policy. The National Institute on Aging (NIA) has established the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) as a resource to serve as a repository for many types of data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples. NIAGADS operates under the NIH Genomics Data Sharing Policy (GDS) and the NIA Genetics of Alzheimer’s Disease Data Sharing Policy. Because the human genomic and phenotypic data contained in NIAGADS is, in some instances, potentially sensitive information, e.g., data related to the presence or risk of developing Alzheimer’s Disease and related neurodegenerative disorders, and information regarding family relationships or ancestry, data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the National Institute on Aging (NIA) that approved users of datasets obtained through this NIAGADS Data Access Request (DAR) recognize any restrictions on data use established by the submitting institution through the Institutional Certification and stated on the NIAGADS website ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/. Definitions of terminology in this document are found in section 14. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution as represented by the Institutional Signing Official (the “Requester”), and NIAGADS. The effective date of this agreement shall be the Project Approval Date, as specified on the NIAGADS approval notification.
View SourceView Similar (10)
Introduction and Statement of Policy. The National Institutes of Health (NIH) has established the Rapid Acceleration of Diagnostics (RADxSM) Data Hub for securely storing and sharing human data submitted to NIH as part of the RADxSM program. Because the volume of human data maintained in this data repository is substantial and potentially sensitive (e.g., data related to the presence or risk of developing particular diseases or conditions and information regarding family relationships or ancestry), data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to RADxSM data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. NIH expects that, through Data Access Request (DAR) process, approved users of open and controlled-access datasets recognize any restrictions on data use established by the Submitting Institutions through the Institutional Certification. Definitions of the underlined terminology in this document are found in section 13. The parties to this Agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution (the “Requester”) as represented by the Institutional Signing Official designated through the eRA Commons system, and the NIH. The effective date of this Agreement shall be the DAR Approval Date, as specified in the notification of approval of the Data Access Committee (DAC).
View SourceView Similar (2)
Introduction and Statement of Policy. The Women’s Interagency HIV Study (WIHS), funded by the National Institutes of Health (NIH), has an established central host genomic data repository called the WIHS Genomics Database for securely storing and sharing human host genomic data submitted to the WIHS. Implicit in the establishment of the WIHS Genomics Database is that scientific progress in genomic research will be greatly enhanced if the data are readily available to all approved scientific investigators and shared in a manner consistent with the research participants’ informed consent. Access to human genomic data will be provided to research investigators who, along with their WIHS Contact (e.g., site PI), have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the WIHS that approved users of the WIHS Genomics Database datasets recognize any restrictions on data use established by the WIHS stated on the WIHS Concept Sheet, the WIHS Genomic Data Code of Conduct, and the WIHS Genomic Data Use Contract. Definitions of terminology used in this document are found in Appendix 1. This Data Use Agreement (the “Agreement”) is by and between the WIHS Principal Investigators [Drs. ▇▇▇▇ ▇▇▇▇▇▇▇▇ and ▇▇▇▇ ▇▇▇▇▇▇▇ (▇▇▇▇▇ University); and Dr. ▇▇▇▇ ▇▇▇▇▇ (Georgetown University); and Drs. ▇▇▇▇▇▇▇ ▇▇▇▇▇ and ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ (▇▇▇▇▇ ▇▇▇▇▇▇▇ University); and ▇▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ (Montefiore Medical Center); and Drs. ▇▇▇▇▇▇ ▇▇▇▇▇ and ▇▇▇▇▇▇ ▇▇▇▇▇▇ (Chicago WIHS Consortium : Cook County Hospital, University of Illinois at Chicago, Rush-Presbyterian-St. Luke's Medical Center, and Northwestern Memorial Hospital); and Drs. ▇▇▇▇▇▇▇ ▇▇▇▇ and ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ (The University of Alabama at Birmingham); and Drs. ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇ and ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ (The University of California at San Francisco); and Drs. ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ and ▇▇▇▇ ▇▇▇▇▇▇ (The University of Miami); and ▇▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇- Parker (The University of Mississippi at ▇▇▇▇▇▇▇); and ▇▇. ▇▇▇ ▇▇▇▇▇▇▇ (The University of North Carolina at Chapel Hill); and Drs. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ (The State University of New York at Brooklyn), (hereinafter referred to individually as “WIHS CONSORTIUM”) and [INSERT INVESTIGATOR NAME] (“Approved User”). This agreement (“Agreement”) establishes the terms and conditions under which the User will obtain and use certain data (“Genomics Dataset”) from the Women’s Interagency HIV Study (WIHS) maintained by the WIHS Consortium. The effective date of ...
View Source
Introduction and Statement of Policy. The National Institutes of Health (NIH) has developed central data repositories to archive and distribute the results of studies provided by Contributing Investigators examining the relationship between genomic data (e.g., genotype, sequence, or epigenetic information) and phenotype. Such studies include genome-wide association studies, medical sequencing, and molecular diagnostic assays. Implicit in the establishment of the NIH data repositories, for example the database of Genotypes and Phenotypes (dbGaP), is the view that scientific progress in this area will be greatly enhanced if the data produced by these studies are readily available to all investigators in the research community. Dataset access will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of the NIH and National Institute on Aging (NIA) that Approved Users of NIH-provided datasets recognize any restrictions on data use delineated within the original informed consent agreements of contributing studies, as identified by the submitting institutions and stated on database websites. Definitions of terminology used in this document are found in the Appendix. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (“the Approved User”), his/her home institution as represented by the Institutional Signing Official designated through the eRA Commons system (“the Requester”), and the NIA, NIH. The effective date of this agreement shall be the Project Approval Date, as specified on the Data Access Committee approval notification.
View Source

Related to Introduction and Statement of Policy

  • Statement of Policy The Employer shall issue and make available to the Union a statement of policy in respect to leaves of absence and any other assistance which it may make available to Employees who desire to seek leave for educational purposes.

  • Form of Policies The minimum limits of policies of insurance required of Tenant under this Lease shall in no event limit the liability of Tenant under this Lease. Such insurance shall: (i) name Landlord, and any other party it so specifies in writing to Tenant, as an additional insured with respect to the commercial general liability insurance; (ii) specifically cover the liability assumed by Tenant under this Lease, including, but not limited to, Tenant’s obligations under Section 10.1 above; (iii) be issued by an insurance company having a rating of not less than A–/VII in Best’s Insurance Guide or which is otherwise acceptable to Landlord and authorized to do business in the state in which the Project is located; (iv) be primary insurance as to all claims thereunder and provide that any insurance carried by Landlord is excess and is non-contributing with any insurance requirement of Tenant; (v) provide that said insurance shall not be canceled or coverage changed unless thirty (30) days’ prior written notice shall have been given to Landlord and any mortgagee or ground or underlying lessor of Landlord (provided Tenant will not be in default if the insurance company refuses to provide such assurance); (vi) contain a cross-liability endorsement or severability of interest clause acceptable to Landlord; and (vii) with respect to the insurance required in Sections 10.3.1, 10.3.2 and 10.3.4 above, have deductible amounts not exceeding One Hundred Thousand Dollars ($100,000.00). Tenant shall deliver certificates thereof to Landlord on or before the Lease Commencement Date and at least thirty (30) days before the expiration dates thereof. If Tenant shall fail to procure such insurance, or to deliver such certificates and endorsements, within such time periods, Landlord may, at its option, in addition to all of its other rights and remedies under this Lease, and without regard to any notice and cure periods set forth in Section 19.1, procure such policies for the account of Tenant, and the cost thereof shall be paid to Landlord as Additional Rent within thirty (30) days after delivery of bills therefor.

  • Dissemination of Policy All members of the contractor's staff who are authorized to hire, supervise, promote, and discharge employees, or who recommend such action, or who are substantially involved in such action, will be made fully cognizant of, and will implement, the contractor's EEO policy and contractual responsibilities to provide EEO in each grade and classification of employment. To ensure that the above agreement will be met, the following actions will be taken as a minimum: a. Periodic meetings of supervisory and personnel office employees will be conducted before the start of work and then not less often than once every six months, at which time the contractor's EEO policy and its implementation will be reviewed and explained. The meetings will be conducted by the EEO Officer. b. All new supervisory or personnel office employees will be given a thorough indoctrination by the EEO Officer, covering all major aspects of the contractor's EEO obligations within thirty days following their reporting for duty with the contractor. c. All personnel who are engaged in direct recruitment for the project will be instructed by the EEO Officer in the contractor's procedures for locating and hiring minorities and women. d. Notices and posters setting forth the contractor's EEO policy will be placed in areas readily accessible to employees, applicants for employment and potential employees. e. The contractor's EEO policy and the procedures to implement such policy will be brought to the attention of employees by means of meetings, employee handbooks, or other appropriate means.